Cancer Outreach Associates, Pc

Abingdon, Virginia 24211

0 studies enrolling now · 8 studies all time

What they study most

Bladder Cancer, Breast Cancer, Cancer, Chronic Lymphocytic Leukemia, Clear Cell Renal Carcinoma, Hormone-Refractory Prostate Cancer, Mantle Cell Lymphoma, Metastasis, Neutropenia, Non-Small Cell Lung Carcinoma, Pain, Transitional Cell Carcinoma

Studies at this site

• TroVax Renal Immunotherapy Survival Trial — Completed
• Albumin-bound Paclitaxel (ABI-007) for Patients With Advanced Non-Small Cell Lung Cancer — Completed
• Study of the Combination of Rituximab, Cyclophosphamide, Doxorubicin, VELCADE, and Prednisone or Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Mantle Cell Lymphoma — Completed
• First-Line Treatment of Advanced Bladder Cancer Randomized vs. Gemcitabine ± Vinflunine in Patients Ineligible to Receive Cisplatin-Based Therapy — Completed
• OraVescent Fentanyl (OVF) for the Treatment of Breakthrough Pain in Opioid Tolerant Cancer Patients — Completed
• Safety and Efficacy Study of GCSF Therapy to Treat Patients at High Risk for Chemotherapy Induced Severe Neutropenia — Completed
• Multi-Center Phase II Study to Compare MER-101 20mg Tablets to Intravenous Zometa 4mg in Male Bisphosphonate-Naive, Hormone Refractory Prostate Cancer Patients — Completed
• Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia. — Status unconfirmed